This is a firm-fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of MEKINIST 2 MG TABLET medical products, with an ultimate completion date of July 7, 2025 and a ceiling value of $46,804.35. The contract is not set-aside and was awarded on June 12, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the supply of MEKINIST 0.05 MG/ML SOLUTION 90ML pharmaceutical products. The contract is a firm-fixed price, with a ceiling value of $6,064.14 and an ultimate completion date of August 22, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies to provide a wide range of...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order with a Firm Fixed Price pricing type and a Ceiling Value of $4,460.92. The contract was awarded by the Defense Logistics Agency (DLA) for the supply of the pharmaceutical product MEKINIST 0.05 MG/ML SOLUTION 90ML. The contract has an Ultimate Completion Date of June 30, 2025 and was awarded on June 6, 2025. The contract is not designated as a Set-Aside. Amerisourcebergen Drug...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The $29,011.53 firm fixed price delivery order is for the supply of MEKINIST 2 MG TABLET UU 30S, a pharmaceutical product. The contract has an ultimate completion date of February 12, 2025. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,460.92, is for the supply of MEKINIST 0.05 MG/ML SOLUTION 90ML, a pharmaceutical product. The contract has an ultimate completion date of February 13, 2025 and is a firm fixed-price agreement. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp, the prime...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA), a defense agency, to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of the pharmaceutical product MEKINIST 2 MG TABLET UU 30S, with a ceiling value of $19,341.02 and a performance period through June 2, 2025. The contract is designated as a Firm Fixed Price Delivery Order, without any set-aside requirements. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of the drug MEKINIST 2 MG TABLET UU 30S, with a ceiling value of $16,588.64 and a period of performance through June 2, 2025. The contract is not set aside and was awarded on May 9, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical company AmerisourceBergen Corporation. The contract is for the delivery of MEKINIST 2 MG TABLET pharmaceutical products, with a ceiling value of $17,018.12 and a period of performance through April 22, 2024. AmerisourceBergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA Troop Support...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a global pharmaceutical distribution company. The contract is for the provision of MEKINIST 0.5 MG TABLET, a specialty pharmaceutical product. The firm fixed price delivery order has a potential value of $7,769.10 and a completion date of March 1, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA valued at up to...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,552.49, is for the delivery of 4566883401 - MEKINIST 0.5 MG TABLET UU 30S. The contract has an ultimate completion date of January 31, 2025 and was awarded on January 9, 2025. The contract does not have a set-aside designation, indicating it was open competition....